Track the 엘앤씨바이오 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 엘앤씨바이오 has recorded 17 public disclosures. Market capitalisation: €1,329.2bn. The latest transaction was disclosed on 23 September 2026 (Purchase). Among the most active insiders: 나우아이비19호펀드. Every trade is free.
11
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
3 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 엘앤씨바이오 Buy (bullish), based on 3 analysts. Average price target: ₩95,000.
Fundamental score
Ranked 22,633 of 29,254 companies
32.7
score / 100
Value
26
Quality
39
FCF yld-0.4%
Earn yld-12%
EV/EBITDA·
ROE-45%
Gross mgn53%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
엘앤씨바이오 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative biopharmaceutical solutions.